Company Short-Term Debt: Applied DNA Sciences Inc (APDN)

Public company logo of Applied DNA Sciences (APDN)

Applied DNA Sciences (APDN) management is effectively allocating resources between biotechnology and cargo security, as confirmed by the stock quotes on this chart, where the indicator stands at 0.00. The business relies on a flexible molecular tagging system available to various industries at low cost. The current development vector is based on increasing the number of B2B deals for the supply of reagents for medical research and DNA synthesis.

APDN Applied DNA Sciences, Inc. Current Liabilities (07/04/2022 - 10/07/2025)

Metric breakdowns and analytics for Applied DNA Corp (APDN)

- stock price and consensus target price:
Stock Price Applied DNA Sciences, Inc.|APDN - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Applied DNA Sciences, Inc.|APDN - Full Business Value
- shareholders' equity book value data:
Net Assets per Single Share Applied DNA Sciences|APDN - Net Asset Value|Market Value to Book Value Ratio adnas.com|APDN - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Applied DNA Sciences|APDN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Applied DNA Sciences|APDN - Company Cumulative Debt|Debts to Book Capitalization Applied DNA Sciences, Inc.|APDN - Company Long-Term Indebtedness|Company Current Liabilities Applied DNA Sciences|Quick Ratio adnas.com
- earnings and multiples data:
APDN - Company Profit
Basic company analysis:Applied DNA Sciences, Inc. (APDN)
Manufactured products of Applied DNA Corp

Uninterrupted supplies of synthetic DNA components require precise working capital management, which directly impacts current liability levels. This indicator measures the aggregate of obligations maturing within twelve months, allowing for an assessment of liquidity and default risk through the analysis of short-term credit obligations. Monitoring this metric protects the assets of Applied DNA Sciences (APDN) from excessive debt pressure, ensuring the business's financial stability.

Direct competitors

Tempus AI, Inc - Company Short-Term Debts|QGEN - Company Short-Term Debts|Ionis Pharma (IONS) - Company Short-Term Debt|Current Liabilities RGEN (Repligen Inc.)|Company Short-Term Debt Avidity Biosciences|crisprtx.com - Current Liabilities|Company Short-Term Debt GeneDx (WGS)|Company Short-Term Debt RARE (Ultragenyx Pharmaceutical Inc.)|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Short-Term Debt Volume Sarepta Corp (SRPT)|Twist Bioscience - Company Short-Term Debts|Short-Term Debt 10xgenomics.com|NTLA: Company Short-Term Debts|Company Short-Term Indebtedness STOK|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|sionnatx.com - Company Short-Term Indebtedness|Company Short-Term Debt Prime Medicine PRME|TSHA: Company Short-Term Indebtedness|uniQure Corp - Company Short-Term Debts|MGTX - Company Short-Term Debts|RGNX (REGENXBIO Inc.) - Company Current Liabilities|solidbio.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Ocugen|Pacific Biosciences of California, Inc. (PACB) - Short-Term Debt Volume|Company Short-Term Debts BNTC|Company Current Liabilities Design Corp DSGN|Company Short-Term Debts RCKT (Rocket Pharmaceuticals)|Short-Term Debt Volume 4dmoleculartherapeutics.com (FDMT)|Lexeo - Company Short-Term Debts|Short-Term Debt Korro Bio, Inc.|Editas (EDIT) - Company Short-Term Debt|Company Short-Term Indebtedness SLN|PRQR (ProQR) - Company Short-Term Debts|Company Current Liabilities Codexis Bio (CDXS)|Company Short-Term Debts SGMO|NAUT - Short-Term Debt|Company Short-Term Debt Metagenomi, Inc MGX|Short-Term Debt Volume precisionbiosciences.com (DTIL)|Generation Bio Corp - Company Short-Term Debts|BOLD - Company Short-Term Debts|exicuretx.com (XCUR) - Company Short-Term Debt|Current Liabilities IMNN (Imunon)|PHIO (Phio Pharmaceuticals Corp) - Company Short-Term Debts|Company Short-Term Indebtedness MBIO (Mustang Bio Corp)|Company Short-Term Debt TransCode Therapeutics (RNAZ)|bionanogenomics.com - Company Short-Term Indebtedness|Company Short-Term Debts BLUE (bluebird bio)|IPA: Company Short-Term Indebtedness|OMGA - Company Short-Term Debt|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|RGLS: Company Short-Term Debts|syros.com (SYRS) - Company Short-Term Debts|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debt Unity Bio (UBX)